Hanny Al-samkari, Md
Clinical trials sponsored by Hanny Al-samkari, Md, explained in plain language.
-
Drug trial targets debilitating bleeding disorder
Disease control OngoingThis study is testing whether the drug bevacizumab can help control chronic bleeding and severe anemia in adults with Hereditary Hemorrhagic Telangiectasia (HHT), a genetic disorder that causes fragile, abnormal blood vessels. Participants receive the drug for 24 weeks while rese…
Phase: PHASE2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope to keep cancer treatment on track: drug trial targets Chemotherapy's dangerous side effect
Disease control OngoingThis study is testing if a drug called avatrombopag can help patients with gastrointestinal cancers who develop persistently low platelet counts from their chemotherapy. Low platelets can cause dangerous bleeding and force doctors to delay or reduce chemotherapy doses. About 60 p…
Phase: PHASE2 • Sponsor: Hanny Al-Samkari, MD • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC